Megavitamin and dietary treatment in schizophrenia: a randomised, controlled trial
- PMID: 10197889
- DOI: 10.1046/j.1440-1614.1999.00527.x
Megavitamin and dietary treatment in schizophrenia: a randomised, controlled trial
Abstract
Objective: The aim of this study was to assess the efficacy of adjunctive megavitamin and dietary treatment in schizophrenia.
Method: A random allocation double-blind, controlled comparison of dietary supplement and megavitamin treatment, and an alternative procedure was given for 5 months to 19 outpatients with a diagnosis of schizophrenia. In addition to usual follow-up, the experimental group received amounts of megavitamins based on their individual serum vitamin levels plus dietary restriction based on Radioallergosorbent (RAST) tests. The control group received 25 mg vitamin C and were prescribed substances considered allergenic from the RAST test.
Results: Five months of treatment showed marked differences in serum levels of vitamins but no consistent self-reported symptomatic or behavioural differences between groups.
Conclusions: This study does not provide evidence supporting a positive relationship between regulation of levels of serum vitamins and clinical outcome in schizophrenia over 5 months.
Similar articles
-
Effects of megavitamin therapy on children with attention deficit disorders.Pediatrics. 1984 Jul;74(1):103-11. Pediatrics. 1984. PMID: 6234505 Clinical Trial.
-
Megavitamins for minimal brain dysfunction. A placebo-controlled study.JAMA. 1978 Dec 8;240(24):2642-3. JAMA. 1978. PMID: 712981 Clinical Trial.
-
Megavitamin and orthomolecular therapy of schizophrenia.Can Psychiatr Assoc J. 1975 Mar;20(2):97-100. doi: 10.1177/070674377502000201. Can Psychiatr Assoc J. 1975. PMID: 1164702 No abstract available.
-
An orthomolecular approach to the prevention and treatment of psychiatric disorders.Adv Mind Body Med. 2012 Fall;26(2):14-28. Adv Mind Body Med. 2012. PMID: 23341413 Review.
-
Orthomolecular medicine: the therapeutic use of dietary supplements for anti-aging.Clin Interv Aging. 2006;1(3):261-5. doi: 10.2147/ciia.2006.1.3.261. Clin Interv Aging. 2006. PMID: 18046879 Free PMC article. Review.
Cited by
-
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.Antioxid Redox Signal. 2011 Oct 1;15(7):2011-35. doi: 10.1089/ars.2010.3603. Epub 2011 Apr 21. Antioxid Redox Signal. 2011. PMID: 21126177 Free PMC article. Review.
-
Fatty acid and vitamin interventions in adults with schizophrenia: a systematic review of the current evidence.J Neural Transm (Vienna). 2015 Dec;122(12):1721-32. doi: 10.1007/s00702-015-1451-z. Epub 2015 Sep 9. J Neural Transm (Vienna). 2015. PMID: 26354100 Review.
-
Biomarker Case-Detection and Prediction with Potential for Functional Psychosis Screening: Development and Validation of a Model Related to Biochemistry, Sensory Neural Timing and End Organ Performance.Front Psychiatry. 2016 Apr 14;7:48. doi: 10.3389/fpsyt.2016.00048. eCollection 2016. Front Psychiatry. 2016. PMID: 27148083 Free PMC article.
-
Natural Medicines for Psychotic Disorders: A Systematic Review.J Nerv Ment Dis. 2018 Feb;206(2):81-101. doi: 10.1097/NMD.0000000000000782. J Nerv Ment Dis. 2018. PMID: 29373456 Free PMC article.
-
Navigating Nutritional Inequality in Schizophrenia: A Comprehensive Exploration of Diet, Genetics, and Holistic Management Across the Life Cycle.Nutrients. 2024 Oct 31;16(21):3738. doi: 10.3390/nu16213738. Nutrients. 2024. PMID: 39519571 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical